Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

EAU 2024: Bladder cancer latest

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Global trends and inequalities in breast cancer survival and care

Multiple myeloma in a resource constrained setting

Updates on lung cancer from WCLC and ESMO 2023

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk BCR after radical RP